Home ›
Trademark Categories ›
Pharmaceuticals ›
2003 ›
SI ›
SIGENE
Trademark search for:
SIGENE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2003-03-05 — Application filed
2003-04-25 — Preliminary/voluntary amendment - entered
2003-04-25 — Teas voluntary amendment received
2003-04-25 — Correspondence received in law office
2003-08-15 — Letter of suspension mailed
2003-08-15 — Assigned to examiner
2004-09-03 — Report completed suspension check case still suspended
2005-03-11 — Report completed suspension check case still suspended
2005-09-12 — Report completed suspension check case still suspended
2006-03-22 — Report completed suspension check case still suspended
2006-10-26 — Report completed suspension check case still suspended
2007-05-07 — Assigned to lie
2007-05-07 — Suspension checked - to attorney for action
2007-05-27 — Approved for pub - principal register
2007-06-07 — Law office publication review completed
2007-06-20 — On hold - electronic record review required
2007-07-10 — Electronic record review complete
2007-07-25 — Notice of publication
2007-08-14 — Published for opposition
2007-09-10 — Extension of time to oppose received
2007-12-12 — Opposition instituted no. 999999
2008-01-09 — Attorney/dom.rep.revoked and/or appointed
2008-01-09 — Teas revoke/app/change addr of atty/dom rep received
2008-03-20 — Teas change of correspondence received
2008-03-25 — Fax received
2008-07-24 — Application abandoned
2008-07-24 — Application abandoned
2008-07-24 — Opposition sustained no. 999999
2008-07-24 — Opposition terminated no. 999999
2008-07-24 — Final status recorded
Owner Information
Ribozyme Pharmaceuticals Incorporated
Boulder , CO
Ribozyme Pharmaceuticals Incorporated
Boulder , CO
Correspondent
Debra A. Shelinsky Greene Merck & Co., Inc. One Merck Drive, P.O. Box 100 Whitehouse Station, NJ 08889-0100 UNITED STATES
Filing Details
Filing Date:
2003-03-05
Status Date:
2008-07-24
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.